stars 1 stars 2 stars 3

R-Pharm Group introduces comprehensive solutions for the healthcare system and focuses on research, development, manufacturing and commercialization of pharmaceuticals, laboratory equipment and medical devices. Our mission is to increase the accessibility of advanced diagnostics, preventative care and therapy methods in Russia and abroad. More than 5000 employees of the group do their best to provide as many people as possible with the necessary means to improve and prolong their lives. R-Pharm’s 11 state-of-the-art manufacturing sites are functioning in accordance with international quality standards. The group has signed agreements on strategic partnership, production localization and technology transfer with the world's leading manufacturers of pharmaceuticals and medical equipment. The most important activities of the group include research and development. Today, R-Pharm’s research pipeline contains more than 100 knowledge-intensive products, which makе a serious contribution to the fight against high burden diseases. Following corporate social responsibility policies, R-Pharm organizes projects aiming to increase awareness about dangerous diseases, promote healthy lifestyle, improve the educational system and foster a new generation of professionals in the pharmaceutical industry. Contacts for Export and International Partnerships: export@rpharm.ru

R-Pharm Questions

The R-Pharm annual revenue was $1.7 billion in 2026.

Oleg Rynskov is the CIO of R-Pharm.

335 people are employed at R-Pharm.

R-Pharm is based in Moscow, Moscow.

The NAICS codes for R-Pharm are [325, 4461, 32, 44, 446].

The SIC codes for R-Pharm are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users